Precision medicine and personalized breast cancer: combination pertuzumab therapy

Trastuzumab (Herceptin), a monoclonal antibody directed against the human epidermal growth-factor receptor 2 (HER2), is the poster child for antibody-based targeted therapy in breast cancer. Pertuzumab, another humanized monoclonal antibody, binds to a different domain of HER2 and prevents the forma...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Reynolds, Kerry, Sarangi, Sasmit, Bardia, Aditya, Dizon, Don S
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2014
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3977457/
https://ncbi.nlm.nih.gov/pubmed/24715764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S37100
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller